But FDA says response from the pharmaceutical industry is underwhelming, even after the agency extended the deadline for supplemental applications to April 6, 1997. In November, FDA sent a letter to 250 manufacturers asking whether and when companies intended to file supplements. FDA received only 40 responses by December. FDA said the absence of adequate pediatric labeling "continues to present a significant health issue" and added that the level of response to the 1994 final rule is a cause for concern.
FDA worried about pediatric drug labeling
The Food & Drug Administration (FDA) continues its effort to ensure that drug labels contain sufficient information about use for children. In December '94, FDA required manufacturers to determine if the pediatric use sections of labeling could be modified "based on adequate and well-controlled studies in adults and other supporting information." Companies would then submit a supplemental pediatric application where appropriate.
Jan 31, 1997
Recommended
Recommended
Machinery Basics
Sponsor Content
2024 PACK EXPO Innovations Reports
Exclusive access: Packaging World editor-curated reports revealing PACK EXPO's most groundbreaking technologies across food, healthcare, and machinery sectors. Each report features truly innovative solutions selected from hundreds of exhibitors by our expert team. Transform your operations with just one click.
Access Now
Break out of the ordinary: see what’s new in packaging & processing!
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this September to experience a breakthrough in packaging and processing.
REGISTER NOW AND SAVE
